H Yamauchi1, S Kagawa2, Y Kishibe2, M Takahashi2, T Higashi2,3. 1. From the Division of PET Imaging (H.Y., S.K., Y.K., M.T., T.H.), Shiga Medical Center Research Institute, Moriyama, Japan yamauchi@res.med.shiga-pref.jp. 2. From the Division of PET Imaging (H.Y., S.K., Y.K., M.T., T.H.), Shiga Medical Center Research Institute, Moriyama, Japan. 3. National Institute of Radiological Sciences (T.H.), National Institutes of Quantum and Radiological Science and Technology, Chiba, Japan.
Abstract
BACKGROUND AND PURPOSE: Misery perfusion may cause selective neuronal damage in atherosclerotic ICA or MCA disease. Bypass surgery can improve misery perfusion and may prevent neuronal damage. On the other hand, surgery conveys a risk for neuronal damage. The purpose of this retrospective study was to determine whether progression of cortical neuronal damage in surgically treated patients with misery perfusion is larger than that in surgically treated patients without misery perfusion or medically treated patients with misery perfusion. MATERIALS AND METHODS: We evaluated the distribution of benzodiazepine receptors twice by using PET and 11C-labeled flumazenil in 18 surgically treated patients with atherosclerotic ICA or MCA disease (9 with misery perfusion and 9 without) and no perioperative stroke before and after bypass surgery; in 8 medically treated patients with misery perfusion and no intervening ischemic event; and in 7 healthy controls. We quantified abnormal decreases in the benzodiazepine receptors of the cerebral cortex within the MCA distribution and compared changes in the benzodiazepine receptor index among the 3 groups. RESULTS: The change in the benzodiazepine receptor index in surgically treated patients with misery perfusion (27.5 ± 15.6) during 7 ± 5 months was significantly larger than that in surgically treated patients without misery perfusion (-5.2 ± 9.4) during 6 ± 4 months (P < .001) and in medically treated patients with misery perfusion (3.2 ± 15.4) during 16 ± 6 months (P < .01). CONCLUSIONS: Progression of cortical neuronal damage in surgically treated patients with misery perfusion and no perioperative stroke may occur and may be larger than that in medically treated patients with misery perfusion and no intervening ischemic event.
BACKGROUND AND PURPOSE: Misery perfusion may cause selective neuronal damage in atherosclerotic ICA or MCA disease. Bypass surgery can improve misery perfusion and may prevent neuronal damage. On the other hand, surgery conveys a risk for neuronal damage. The purpose of this retrospective study was to determine whether progression of cortical neuronal damage in surgically treated patients with misery perfusion is larger than that in surgically treated patients without misery perfusion or medically treated patients with misery perfusion. MATERIALS AND METHODS: We evaluated the distribution of benzodiazepine receptors twice by using PET and 11C-labeled flumazenil in 18 surgically treated patients with atherosclerotic ICA or MCA disease (9 with misery perfusion and 9 without) and no perioperative stroke before and after bypass surgery; in 8 medically treated patients with misery perfusion and no intervening ischemic event; and in 7 healthy controls. We quantified abnormal decreases in the benzodiazepine receptors of the cerebral cortex within the MCA distribution and compared changes in the benzodiazepine receptor index among the 3 groups. RESULTS: The change in the benzodiazepine receptor index in surgically treated patients with misery perfusion (27.5 ± 15.6) during 7 ± 5 months was significantly larger than that in surgically treated patients without misery perfusion (-5.2 ± 9.4) during 6 ± 4 months (P < .001) and in medically treated patients with misery perfusion (3.2 ± 15.4) during 16 ± 6 months (P < .01). CONCLUSIONS: Progression of cortical neuronal damage in surgically treated patients with misery perfusion and no perioperative stroke may occur and may be larger than that in medically treated patients with misery perfusion and no intervening ischemic event.
Authors: H Okazawa; H Yamauchi; K Sugimoto; M Takahashi; H Toyoda; Y Kishibe; H Shio Journal: J Cereb Blood Flow Metab Date: 2001-07 Impact factor: 6.200
Authors: R S Marshall; J R Festa; Y K Cheung; R Chen; M A Pavol; C P Derdeyn; W R Clarke; T O Videen; R L Grubb; H P Adams; W J Powers; R M Lazar Journal: Neurology Date: 2012-01-11 Impact factor: 9.910
Authors: Randolph S Marshall; Joanne R Festa; Ying-Kuen Cheung; Marykay A Pavol; Colin P Derdeyn; William R Clarke; Tom O Videen; Robert L Grubb; Kevin Slane; William J Powers; Ronald M Lazar Journal: Neurology Date: 2014-01-29 Impact factor: 9.910
Authors: Bixiao Cui; Yi Shan; Tianhao Zhang; Yan Ma; Bin Yang; Hongwei Yang; Liqun Jiao; Baoci Shan; Jie Lu Journal: Ann Nucl Med Date: 2022-07-05 Impact factor: 2.258